Press Releases

FEATURE REPORT! -- MARCH 19, 2019

AMAZON SALES INCREASE 143%; GLUCODOWN® WINNING vs. SLIMFAST, GLUCERNA & BOOST.

GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) (“Company”), is not only generating impressive sales growth on Amazon; its winning the battle vs. long-established brands in the diabetic nutritional category, including from manufacturers SlimFast, Abbott Labs and Nestle. GLUCODOWN®, in its first 4-week period of Amazon availability (October-November 2018), generated revenues of $5,907 from 464 containers sold.  In the latest 4-week period (February-March 2019),...

Read more

March 13, 2019 -- FDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling

BENTONVILLE AR – GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: “GLUC”), is the leading functional tea beverage in the over-the-counter diabetic nutritional retail category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic.1 Food and Drug Administration (“FDA”) regulations2 enacted in 2016, provide that only forms of dietary fiber demonstrating a “beneficial physiological effect on human health”, can be declared on nutritional supplement product labels, as dietary fiber. More than two years ago, a...

Read more

February 25, 2019 -- US Patent Office Awards GLUCODOWN® Trademark For Expanded Distribution of New Diabetic Tea Flavors

BENTONVILLE AR – GLUCOSE HEALTH, INC. (OTC: “GLUC”) today confirmed it has secured registration of the trademark GLUCODOWN® following a detailed review process, from the United States Patent & Trademark Office (“USPTO”). GLUCOSE HEALTH, INC. was successfully awarded the highest level of trademark protection possible from the USPTO, with registration of GLUCODOWN® on the principal register (Reg. # 5572054). Use of the GLUCODOWN trademark was first achieved outside of the United States, by HanAll Bio...

Read more

November 14, 2018 -- Glucose Health, Inc. Reports Higher Revenues & Gross Profits; Lower Operating Costs.

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data for the 9-month period ended September 30, 2018 vs. the 9-month period ended September 30, 2017, posted this morning at OTCMarkets.com.

  1. Revenues of $158,482; a 117% increase compared to the prior 2017 period.
  2. Operating Expenses of $54,590; a 16% decrease compared to the prior 2017 period.
  3. Gross Profits of $86,162; a 51% increase compared to the prior 2017 period.
  4. Net Assets of $165,256; a 138% increase
  5. ...

Read more